We sourced in the Gliovis dataset and we found that in the Chinese Glioma Genome Atlas (CGGA), the prognosis of patients with high ADRA1D gene expression was significantly worse than that of patients with low expression (Fig. 6E, p value=0.0066). The gene discussed is ADRA1D; the disease is central nervous system cancer.